{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:32:21Z","timestamp":1740148341173,"version":"3.37.3"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":["ecco-jccjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.crohns.2013.11.018","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T10:46:16Z","timestamp":1386240376000},"page":"439-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["HAHA antibodies \u2014 Not such a funny story"],"prefix":"10.1093","volume":"8","author":[{"given":"B.","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2013.11.018_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","article-title":"BIOGEAS study group biologics-induced autoimmune diseases","volume":"25","author":"Perez-Alvarez","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.crohns.2013.11.018_bb0010","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0149-2918(02)80075-3","article-title":"Immunogenicity of therapeutic proteins: clinical implications and future prospects","volume":"24","author":"Schellekens","year":"2002","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.crohns.2013.11.018_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0300-483X(95)03123-W","article-title":"Side-effects of a monoclonal antibody, muromonab CD3\/orthoclone OKT3: bibliographic review","volume":"105","author":"Sgro","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.crohns.2013.11.018_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/annrheumdis-2012-202545","article-title":"Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective","volume":"72","author":"Vincent","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.crohns.2013.11.018_bb0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4161\/mabs.2.6.13601","article-title":"Have we overestimated the benefit of human(ized) antibodies?","volume":"2","author":"Getts","year":"2010","journal-title":"MAbs"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613004078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994613004078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/8\/5\/439\/1704429\/8-5-439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T04:20:55Z","timestamp":1503462055000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2013.11.018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1873994613004078"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2013.11.018","relation":{},"ISSN":["1873-9946"],"issn-type":[{"type":"print","value":"1873-9946"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HAHA antibodies \u2014 Not such a funny story","name":"articletitle","label":"Article Title"},{"value":"Journal of Crohn's and Colitis","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.crohns.2013.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}